Dutch translation and linguistic validation of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™).

Evalien VeldhuijzenIris WalravenSandra A MitchellElizabeth Yohe MooreShawn M McKownMatthew LauritzenKatherine J KimJosé S A BelderbosNeil K Aaronson

Published in: Journal of patient-reported outcomes (2020)

The Dutch language version of PRO-CTCAE has been successfully developed and linguistically validated for use in oncology studies in the Netherlands and Dutch-speaking Belgium. Extending the availability of NCI PRO-CTCAE in languages beyond English increases international consistency in the capture of Patient-Reported outcomes in patients participating in cancer clinical trials.

Keyphrases

patient reported outcomes
clinical trial
anti inflammatory
end stage renal disease
chronic kidney disease
papillary thyroid
autism spectrum disorder
newly diagnosed
ejection fraction
phase ii
patient reported